The type I and type II 11β-hydroxysteroid dehydrogenase enzymes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 391-401

  Krozowski, Z ^a   Li, K X Z ^a   Koyama, K ^a   Smith, R E ^a   Obeyesekere, V R ^a   Stein Oakley, A ^a   Sasano, H ^b   Coulter, C ^a   Cole, T ^a   Sheppard, K E ^a  

^a ALFRED HOSPITAL   (Australia)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; CORTISONE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID RECEPTOR; ISOENZYME; RETINOL DEHYDROGENASE;

ANIMAL MODEL; CONFERENCE PAPER; CORTICOSTEROID BLOOD LEVEL; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; GENE DELETION; GENE INACTIVATION; HYPERTENSION; KIDNEY DISTAL TUBULE; MOUSE; NEWBORN MORTALITY; NONHUMAN; PHYLOGENY; PROTEIN LOCALIZATION; STEROID RELEASE; STEROIDOGENESIS; TISSUE LEVEL;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ARTERIOLES; BRAIN; CORTICOSTERONE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; KIDNEY; NEOPLASMS; PLACENTA; PROTEIN CONFORMATION; RECEPTORS, GLUCOCORTICOID;

EID: 0032977322     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00074-6     Document Type: Conference Paper

References (71)

1. Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J. Biol. Chem. 264:1989;18939-18946.
2. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Molec. Cell Endocr. 105:1994;R11-R17.
3. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 242:1988;583-585.
4. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., deKloet E.R., Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet. 2:1988;986-989.
5. Walker B.R., Campbell J.C., Fraser R., Stewart P.M., Edwards C. Mineralocorticoid excess and inhibition of 11beta-Hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin. Endocr. 37:1992;483-492.
6. Ricketts M.L., Verhaeg J.M., Bujalska I., Howie A.J., Rainey W.E., Stewart P.M. Immunohistochemical localization of type 1 11 beta-hydroxysteroid dehydrogenase in human tissues. J. Clin. Endocr. Metab. 83:1998;1325-1335.
7. Agarwal A.K., Mune T., Monder C., White P.C. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase - Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 269:1994;25959-25962.
8. Smith R.E., Li K.X.Z., Andrews R.K., Krozowski Z. Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology. 138:1997;540-547.
9. Yang K., Smith C.L., Dales D., Hammond G.L., Challis J.R.G. Cloning of an ovine 11beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid - tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology. 131:1992;2120-2126.
10. Nikkila H., Tannin G.M., New M.I., Taylor N.F., Kalaitzoglou G., Monder C., White P.C. Defects in the HSD11 gene encoding 11-beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J. Clin. Endocr. Metab. 77:1993;687-691.
11. Kotelevtsev Y., Holmes M.C., Burchell A., Houston P.M., Schmoll D., Jamieson P., Best R., Brown R., Edwards C.R.W., Seckl J.R., Mullins J.J. 11 beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl Acad. Sci. USA. 94:1997;14924-14929.
12. Bujalska I.J., Kumar S., Stewart P.M. Does central obesity reflect "Cushing's disease of the omentum"? Lancet. 349:1997;1210-1213.
13. Moisan M.P., Seckl J.R., Edwards C.R. 11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology. 127:1990;1450-1455.
14. Low S.C., Moisan M.P., Noble J.M., Edwards C., Seckl J.R. Glucocorticoids regulate hippocampal 11 beta-hydroxysteroid dehydrogenase activity and gene expression in vivo in the rat. J. Neuroendocr. 6:1994;285-290.
15. Seckl J.R., Kelly P.A., Sharkey J. Glycyrrhetinic acid, an inhibitor of 11 beta-hydroxysteroid dehydrogenase, alters local cerebral glucose utilization in vivo. J. Steroid Biochem. Molec. Biol. 39:1991;777-779.
16. Michael A.E., Gregory L., Walker S.M., Antoniw J.W., Shaw R.W., Edwards C., Cooke B.A. Ovarian 11-beta-hydroxysteroid dehydrogenase - potential predictor of conception by in vitro fertilisation and embryo transfer. Lancet. 342:1993;711-712.
17. Brem A.S., Bina R.B., King T.C., Morris D.J. Localization of 2 11 beta-OH steroid dehydrogenase isoforms in aortic endothelial cells. Hypertension. 31:1998;459-462.
18. Walker B.R., Yau J.L., Brett L.P., Seckl J.R., Monder C., Williams B.C., Edwards C.R. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 129:1991;3305-3312.
19. Wilson R.C., Harbison M.D., Krozowski Z.S., Funder J.W., Shackleton C., Hanauskeabel H.M., Wei J.Q., Hertecant J., Moran A., Neiberger R.E., Balfe J.W., Fattah A., Daneman D., Licholai T., New M.I. Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J. Clin. Endocr. Metab. 80:1995;3145-3150.
20. Mune T., Rogerson F.M., Nikkila H., Agarwal A.K., White P.C. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat. Genet. 10:1995;394-399.
21. Stewart P.M., Krozowski Z.S., Gupta A., Milford D.V., Howie A.J., Sheppard M.C., Whorwood C.B. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet. 347:1996;88-91.
22. White P.C., Mune T., Agarwal A.K. 11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrine Rev. 18:1997;135-156.
23. Karet F.E., Lifton R.P. Mutations contributing to human blood pressure variation. Recent Prog. Horm. Res. 52:1997;263-276.
24. Watson B., Bergman S.M., Myracle A., Callen D.F., Acton R.T., Warnock D.G. Genetic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks. Hypertension. 28:1996;478-482.
25. Smolenicka Z., Bach E., Schaer A., Liechti-Gallati S., Frey B.M., Frey F.J., Ferrari P. A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene. J. Clin. Endocr. Metab. 83:1998;1814-1817.
26. Brand E., Kato N., Chatelain N., Krozowski Z.S., Jeunemaitre X., Corvol P., Plouin P.F., Cambien F., Pascoe L., Soubrier F. Structural analysis and evaluation of the 11b-hydroxysteroid dehydrogenase type 2 (11b-HSD2) gene in human essential hypertension. 1998;. Submitted.
27. A.N. Stein-Oakley, J.A. Maguire, J. Dowling, G.J. Perry, Z. Krozowski, N.M. Thompson, 11βHydroxyateroid dehydrogenase type 2 enzyme is expressed in normotensive and hypertensive patients with renal disease, Nephrology (1998) (In Press).
28. Kotelevtsev Y.V., Brown R.W., Fleming S., Edwards C.R.W., Seckl J.R., Mullins J.J. Hypertension in mice caused by inactivation of 11β-hydroxysteroid dehydrogenase type 2. ISH Meeting, Amsterdam. 1998;. Abstract, 1A.4.
29. Edwards C., Benediktsson R., Lindsay R.S., Seckl J.R. Dysfunction of placental glucocorticoid barrier - link between fetal environment and adult hypertension. Lancet. 341:1993;355-357.
30. Stewart P.M., Rogerson F.M., Mason J.I. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: Its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J. Clin. Endocr. Metab. 80:1995;885-890.
31. Diaz R., Brown R.W., Seckl J.R. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J. Neurosci. 18:1998;2570-2580.
32. Teelucksingh S., Mackie A.D., Burt D., McIntyre M.A., Brett L., Edwards C.R. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet. 335:1990;1060-1063.
33. Krozowski Z., Maguire J.A., Stein-Oakley A.N., Dowling J., Smith R.E., Andrews R.K. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocr. Metab. 80:1995;2203-2209.
34. Brown R.W., Chapman K.E., Kotelevtsev Y., Yau J.L.W., Lindsay R.S., Brett L., Leckie C., Murad P., Lyons V., Mullins J.J., Edwards C.R.W., Seckl J.R. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem. J. 313:1996;1007-1017.
35. Beitins I.Z., Bayard F., Ances I.G., Kowarski A., Migeon C.J. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr. Res. 7:1973;509-519.
36. Diederich S., Hanke B., Bahr V., Oelkers W. The metabolism of 9 alpha-fluorinated steroids in the human kidney. Endocrine Res. 22:1996;803-810.
37. Li K.X.Z., Obeyesekere V.R., Krozowski Z.S., Ferrari P. Oxoreductase and dehydrogenase activities of the human and rat 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Endocrinology. 138:1997;2948-2952.
38. Smith M.A., Thomford P.J., Mattison D.R., Slikker W.J. Transport and metabolism of dexamethasone in the dually perfused human placenta. Reprod. Toxicol. 2:1988;37-43.
39. Li K.X.Z., Smith R.E., Ferrari P., Funder J.W., Krozowski Z.S. Rat 11 beta-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney. Molec. Cell Endocr. 120:1996;67-75.
40. Brown R.W., Diaz R., Robson A.C., Kotelevtsev Y.V., Mullins J.J., Kaufman M.H., Seckl J.R. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology. 137:1996;794-797.
41. Roland B.L., Li K., Funder J.W. Hybridization histochemical localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology. 136:1995;4697-4700.
42. Sakai R.R., Lakshmi V., Monder C., Mcewen B.S. Immunocytochemical localization of 11beta-hydroxysteroid dehydrogenase in hippocampus and other brain regions of the rat. J. Neuroendocr. 4:1992;101-106.
43. Gomez-Sanchez E.P., Gomez-Sanchez C.E. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am. J. Physiol. 263:1992;E1125-E1130.
44. Gomez-Sanchez E.P. Central hypertensive effects of aldosterone. Front. Neuroendocr. 18:1997;440-462.
45. Seckl J.R. 11 beta-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action? Front. Neuroendocr. 18:1997;49-99.
46. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C. Glucocorticoid exposure in utero - new model for adult hypertension. Lancet. 341:1993;339-341.
47. O'Donnell D., Larocque S., Seckl J.R., Meaney M.J. Postnatal handling alters glucocorticoid, but not mineralocorticoid messenger RNA expression in the hippocampus of adult rats. Brain Res. Molec. Brain Res. 26:1994;242-248.
48. Kenouch S., Lombes M., Delahaye F., Eugene E., Bonvalet J.P., Farman N. Human skin as target for aldosterone: Coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J. Clin. Endocr. Metab. 79:1994;1334-1341.
49. Smith R.E., Maguire J.A., SteinOakley A.N., Sasano H., Takahashi K.I., Fukushima K., Krozowski Z.S. Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. J. Clin. Endocr. Metab. 81:1996;3244-3248.
50. Walker B.R. Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. Endocrine Res. 22:1996;701-708.
51. Quirk S.J., Gannell J.E., Funder J.W. Aldosterone-binding sites in pregnant and lactating rat mammary glands. Endocrinology. 113:1983;1812-1817.
52. Quirk S.J., Slattery J.A., Funder J.W. Epithelial and adipose cells isolated from mammary glands of pregnant and lactating rats differ in 11 beta-hydroxysteroid dehydrogenase activity. J. Steroid Biochem. Molec. Biol. 37:1990;529-534.
53. Sasano H., Frost A.R., Saitoh R., Matsunaga G., Nagura H., Krozowski Z.S., Silverberg S.G. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders. Anticancer Res. 17:1997;2001-2007.
54. Hundertmark S., Buhler H., Rudolf M., Weitzel H.K., Ragosch V. Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J. Endocr. 155:1997;171-180.
55. Page N., Warriar N., Govindan M.V. 11 beta-Hydroxysteroid dehydrogenase and tissue specificity of androgen action in human prostate cancer cell LNCaP. J. Steroid Biochem. Molec. Biol. 49:1994;173-181.
56. Lerman S.A., Miller G.K., Bohlman K., Albaladejo V., Leonard J.F., Devas V., Clark R.L. Effects of corticosterone on reproduction in male Sprague-Dawley rats. Reprod. Toxicol. 11:1997;799-805.
57. Krozowski Z. 11beta-hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily. Molec. Cell Endocr. 84:1992;C25-C31.
58. Duax W.L., Ghosh D. Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer. Steroids. 62:1997;95-100.
59. Michelson A.M., Blake C.C., Evans S.T., Orkin S.H. Structure of the human phosphoglycerate kinase gene and the intron-mediated evolution and dispersal of the nucleotide-binding domain. Proc. Natl Acad. Sci. USA. 82:1985;6959-6965.
60. Krozowski Z. The short-chain alcohol dehydrogenase superfamily: Variations on a common theme. J. Steroid Biochem. Molec. Biol. 51:1994;125-130.
61. Biswas M.G., Russell D.W. Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate. J. Biol. Chem. 272:1997;15,959-15,966.
62. Ferrari P., Obeyesekere V.R., Li K., Andrews R.K., Krozowski Z.S. The 11 beta-hydroxysteroid dehydrogenase type II enzyme: Biochemical consequences of the congenital R337C mutation. Steroids. 61:1996;197-200.
63. Azzi A., Rehse P.H., Zhu D.W., Campbell R.L., Labrie F., Lin S.X. Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiol [letter]. Nat. Struct. Biol. 3:1996;665-668.
64. Tanaka N., Nonaka T., Tanabe T., Yoshimoto T., Tsuru D., Mitsui Y. Crystal structures of the binary and ternary complexes of 7 alpha-hydroxysteroid dehydrogenase from Escherichia coli. Biochemistry. 35:1996;7715-7730.
65. Gomez-Sanchez E.P., Ganjam V., Chen Y.J., Cox D.L., Zhou M.Y., Thanigaraj S., Gomez-Sanchez C.E. The sheep kidney contains a novel unidirectional, high affinity NADP±dependent 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD-3). Steroids. 62:1997;444-450.
66. Ge R.S., Gao H.B., Nacharaju V.L., Gunsalus G.L., Hardy M.P. Identification of a kinetically distinct activity of 11 beta-hydroxysteroid dehydrogenase in rat Leydig cells. Endocrinology. 138:1997;2435-2442.
67. Michael A.E., Evagelatou M., Norgate D.P., Clarke R.J., Antoniw J.W., Stedman B.A., Brennan A., Welsby R., Bujalska I., Stewart P.M., Cooke B.A. Isoforms of 11 beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Molec. Cell Endocr. 132:1997;43-52.
68. Morris D.J., Latif S.A., Rokaw M.D., Watlington C.O., Johnson J.P. A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy. Am. J. Physiol. 274:1998;C1245-C1252.
69. Sheppard K.E., Funder J.W. Specific nuclear localization of 11-dehydrocorticosterone in rat colon: Evidence for a novel corticosteroid receptor. Endocrinology. 137:1996;3274-3278.
70. Sheppard K.E., Khoo K., Krozowski Z.S., Li K.X.Z. Steroid specificity of the putative dehydrocorticosterone receptor: Evidence that the receptor is not 11β-hydroxysteroid dehydrogenase. Am. J. Physiol. 275:1998;124-131.
71. Sheppard K.E. Decreased apparent affinity of corticosterone for colonic crypt glucocorticoid receptors is dependent on the cellular milieu and is distinct from corticosterone metabolism. J. Steroid Biochem. Molec. Biol. 64:1998;35-42.